Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
Pfaller
M A
MA
Department of Pathology, College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. michael-pfaller@uiowa.edu
Diekema
D J
DJ
D000935:Antifungal Agents / Q000494:pharmacology; D001230:Aspergillus / Q000187:drug effects / Q000472:pathogenicity; D002175:Candida / Q000187:drug effects / Q000472:pathogenicity; D021821:Communicable Diseases, Emerging / Q000382:microbiology*; D025141:Drug Resistance, Fungal; D005658:Fungi / Q000145:classification / Q000187:drug effects* / Q000472:pathogenicity*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000382:microbiology*; D009894:Opportunistic Infections / Q000382:microbiology*; D012233:Rhizopus / Q000187:drug effects / Q000472:pathogenicity; D014250:Trichosporon / Q000187:drug effects / Q000472:pathogenicity
D000935:Antifungal Agents